Accenture will work with BioCelerate, a subsidiary of TransCelerate BioPharma Inc., a nonprofit focused on improving efficiencies in R&D, to develop a platform enabling its member companies to aggregate and analyze preclinical and clinical information to improve drug development efficiency.   “The ability to collect and leverage large amounts of precompetitive information to create new insights in the R&D process is an important development in the preclinical research space, said Kevin...